TY  - JOUR
AU  - Portoles, José
AU  - Huerta, Ana
AU  - Arjona, Emilia
AU  - Gavela, Eva
AU  - Agüera, Marisa
AU  - Jiménez, Carlos
AU  - Cavero, Teresa
AU  - Marrero, Domingo
AU  - Rodríguez de Córdoba, Santiago
AU  - Diekmann, Fritz
AU  - Matrix Investigators
PY  - 2020
DO  - 10.1093/ckj/sfaa096
SN  - 2048-8505
UR  - https://hdl.handle.net/10668/25754
T2  - Clinical kidney journal
AB  - Kidney transplantation (KTx) is a strong trigger for the development of either recurrent or de novo atypical haemolytic uraemic syndrome (aHUS). According to previous studies, eculizumab (ECU) is effective for prophylaxis and for treatment of...
LA  - en
KW  - aHUS atypical haemolytic uraemic syndrome
KW  - aHUS de novo
KW  - eculizumab
KW  - genetic study
KW  - kidney transplantation recurrence
TI  - Characteristics, management and outcomes of atypical haemolytic uraemic syndrome in kidney transplant patients: a retrospective national study.
TY  - research article
VL  - 14
ER  -